• Je něco špatně v tomto záznamu ?

Small colony variants of Staphylococcus aureus - review

O. Melter, B. Radojevič

. 2010 ; 55 (6) : 548-558.

Jazyk angličtina Země Česko

Typ dokumentu přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc12003788

Bacterial variants of Staphylococcus aureus called small colony variants (SCVs) originate by mutations in metabolic genes, resulting in emergence of auxotrophic bacterial subpopulations. These variants are not particularly virulent but are able to persist viable inside host cells. SCVs show their characteristic auxotrophic growth deficiency and depressed α-cytotoxin activity. Environmental pressure such as antibiotics, select for isogenic SCV cells that are frequently found coexisting with their parent wild-type strains in a mixed bacterial culture. SCV strains often grow on blood agar as non-pigmented or pinpoint pigmented colonies and their key biochemical tests are often non-reactive. Their altered metabolism or auxotrophism can result in long generation time and thus SCV phenotype, more often than not SCV can be overgrown by their wild-type counterparts and other competitive respiratory flora. This could affect laboratory detection. Thus, molecular methods, such as 16S rRNA partial sequencing or amplification of species-specific DNA targets (e.g. coagulase, nuclease) directly from clinical material or isolated bacterial colonies, become the method of choice. Patients at risk of infection by S. aureus SCVs include cystic fibrosis patients (CF), patients with skin and foreign-body related infections and osteomyelitis, as they suffer from chronic staphylococcal infections and are subject to long-term antibiotic therapy. Molecular evidence of SCV development has not been found except for some random mutations of the thymidylate synthase gene (thyA) described in SCV S. aureus strains of CF patients. These variants are able to bypass the antibiotic effect of folic acid antagonists such as sulfonamides and trimethoprim. Resistance to gentamicin and aminoglycosides in the hemin or menadione auxotrophic SCVs was hypothesized as being due to decreased influx of the drugs into cells as a result of decreased ATP production and decreased electrochemical gradient on cell membranes.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc12003788
003      
CZ-PrNML
005      
20120209123708.0
007      
ta
008      
120207s2010 xr do| f 000 0eng||
009      
AR
024    7_
$a 10.1007/s12223-010-0089-3 $2 doi
035    __
$a (PubMed)21253898
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Melter, Oto, $7 xx0102242 $u Department of Medical Microbiology, 2nd Medical Faculty, Charles University in Prague, Prague 5-Motol $d 1965-
245    10
$a Small colony variants of Staphylococcus aureus - review / $c O. Melter, B. Radojevič
504    __
$a Literatura
520    9_
$a Bacterial variants of Staphylococcus aureus called small colony variants (SCVs) originate by mutations in metabolic genes, resulting in emergence of auxotrophic bacterial subpopulations. These variants are not particularly virulent but are able to persist viable inside host cells. SCVs show their characteristic auxotrophic growth deficiency and depressed α-cytotoxin activity. Environmental pressure such as antibiotics, select for isogenic SCV cells that are frequently found coexisting with their parent wild-type strains in a mixed bacterial culture. SCV strains often grow on blood agar as non-pigmented or pinpoint pigmented colonies and their key biochemical tests are often non-reactive. Their altered metabolism or auxotrophism can result in long generation time and thus SCV phenotype, more often than not SCV can be overgrown by their wild-type counterparts and other competitive respiratory flora. This could affect laboratory detection. Thus, molecular methods, such as 16S rRNA partial sequencing or amplification of species-specific DNA targets (e.g. coagulase, nuclease) directly from clinical material or isolated bacterial colonies, become the method of choice. Patients at risk of infection by S. aureus SCVs include cystic fibrosis patients (CF), patients with skin and foreign-body related infections and osteomyelitis, as they suffer from chronic staphylococcal infections and are subject to long-term antibiotic therapy. Molecular evidence of SCV development has not been found except for some random mutations of the thymidylate synthase gene (thyA) described in SCV S. aureus strains of CF patients. These variants are able to bypass the antibiotic effect of folic acid antagonists such as sulfonamides and trimethoprim. Resistance to gentamicin and aminoglycosides in the hemin or menadione auxotrophic SCVs was hypothesized as being due to decreased influx of the drugs into cells as a result of decreased ATP production and decreased electrochemical gradient on cell membranes.
650    _2
$a financování organizované $7 D005381
650    _2
$a genetická variace $7 D014644
650    _2
$a lidé $7 D006801
650    _2
$a metabolické sítě a dráhy $x genetika $7 D053858
650    _2
$a mutace $7 D009154
650    _2
$a stafylokokové infekce $x mikrobiologie $7 D013203
650    _2
$a Staphylococcus aureus $x genetika $x metabolismus $x patogenita $x růst a vývoj $7 D013211
650    _2
$a virulence $7 D014774
650    _2
$a faktory virulence $x metabolismus $7 D037521
655    _2
$a přehledy $7 D016454
700    1_
$a Radojevič, B. $7 _AN065713 $u Department of Medical Microbiology, 2nd Medical Faculty, Charles University in Prague, Prague 5-Motol
773    0_
$t Folia microbiologica $x 0015-5632 $g Roč. 55, č. 6 (2010), s. 548-558 $w MED00011005
910    __
$a ABA008 $b A 2403 $c 561 $y 2
990    __
$a 20120207143748 $b ABA008
991    __
$a 20120209123650 $b ABA008
999    __
$a ok $b bmc $g 896672 $s 760560
BAS    __
$a 3
BMC    __
$a 2010 $b 55 $c 6 $d 548-558 $i 0015-5632 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
LZP    __
$a 2012-03/mkme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...